Cargando…

Current Role of Delta Radiomics in Head and Neck Oncology

The latest developments in the management of head and neck cancer show an increasing trend in the implementation of novel approaches using artificial intelligence for better patient stratification and treatment-related risk evaluation. Radiomics, or the extraction of data from various imaging modali...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcu, David C., Grava, Cristian, Marcu, Loredana G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916410/
https://www.ncbi.nlm.nih.gov/pubmed/36768535
http://dx.doi.org/10.3390/ijms24032214
_version_ 1784886119241875456
author Marcu, David C.
Grava, Cristian
Marcu, Loredana G.
author_facet Marcu, David C.
Grava, Cristian
Marcu, Loredana G.
author_sort Marcu, David C.
collection PubMed
description The latest developments in the management of head and neck cancer show an increasing trend in the implementation of novel approaches using artificial intelligence for better patient stratification and treatment-related risk evaluation. Radiomics, or the extraction of data from various imaging modalities, is a tool often used to evaluate specific features related to the tumour or normal tissue that are not identifiable by the naked eye and which can add value to existing clinical data. Furthermore, the assessment of feature variations from one time point to another based on subsequent images, known as delta radiomics, was shown to have even higher value for treatment-outcome prediction or patient stratification into risk categories. The information gathered from delta radiomics can, further, be used for decision making regarding treatment adaptation or other interventions found to be beneficial to the patient. The aim of this work is to collate the existing studies on delta radiomics in head and neck cancer and evaluate its role in tumour response and normal-tissue toxicity predictions alike. Moreover, this work also highlights the role of holomics, which brings under the same umbrella clinical and radiomic features, for a more complex patient characterization and treatment optimisation.
format Online
Article
Text
id pubmed-9916410
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99164102023-02-11 Current Role of Delta Radiomics in Head and Neck Oncology Marcu, David C. Grava, Cristian Marcu, Loredana G. Int J Mol Sci Review The latest developments in the management of head and neck cancer show an increasing trend in the implementation of novel approaches using artificial intelligence for better patient stratification and treatment-related risk evaluation. Radiomics, or the extraction of data from various imaging modalities, is a tool often used to evaluate specific features related to the tumour or normal tissue that are not identifiable by the naked eye and which can add value to existing clinical data. Furthermore, the assessment of feature variations from one time point to another based on subsequent images, known as delta radiomics, was shown to have even higher value for treatment-outcome prediction or patient stratification into risk categories. The information gathered from delta radiomics can, further, be used for decision making regarding treatment adaptation or other interventions found to be beneficial to the patient. The aim of this work is to collate the existing studies on delta radiomics in head and neck cancer and evaluate its role in tumour response and normal-tissue toxicity predictions alike. Moreover, this work also highlights the role of holomics, which brings under the same umbrella clinical and radiomic features, for a more complex patient characterization and treatment optimisation. MDPI 2023-01-22 /pmc/articles/PMC9916410/ /pubmed/36768535 http://dx.doi.org/10.3390/ijms24032214 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Marcu, David C.
Grava, Cristian
Marcu, Loredana G.
Current Role of Delta Radiomics in Head and Neck Oncology
title Current Role of Delta Radiomics in Head and Neck Oncology
title_full Current Role of Delta Radiomics in Head and Neck Oncology
title_fullStr Current Role of Delta Radiomics in Head and Neck Oncology
title_full_unstemmed Current Role of Delta Radiomics in Head and Neck Oncology
title_short Current Role of Delta Radiomics in Head and Neck Oncology
title_sort current role of delta radiomics in head and neck oncology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916410/
https://www.ncbi.nlm.nih.gov/pubmed/36768535
http://dx.doi.org/10.3390/ijms24032214
work_keys_str_mv AT marcudavidc currentroleofdeltaradiomicsinheadandneckoncology
AT gravacristian currentroleofdeltaradiomicsinheadandneckoncology
AT marculoredanag currentroleofdeltaradiomicsinheadandneckoncology